-
JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activities
-
January 15, 2019
- Posted by: eric
- Categories: Optio company news, Uncategorized
-
Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018
-
January 15, 2018
- Posted by: admin
- Categories: Optio company news, Uncategorized
-
Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.
-
June 21, 2017
- Posted by: admin
- Categories: Optio company news, Rare Disease Markets
-
Optio conducts business development interviews for a rare disease product valuation in conjunction with the 35th Annual J.P. Morgan Healthcare Conference.
-
January 9, 2017
- Posted by: admin
- Categories: Market Research NPP, Optio company news
-
Optio Biopharma Solutions attends the 23rd Annual Huntington’s Study Group Meeting and 10th Annual Clinical Research Symposium in Nashville, TN.
-
November 2, 2016
- Posted by: admin
- Categories: Marketing Project Management, Optio company news
